Functional relevance of aldosterone for the determination of left ventricular mass.
In experimental studies, the importance of aldosterone for the development of left ventricular (LV) hypertrophy has been demonstrated. In 120 healthy Caucasian men (aged 25 +/- 3 years; blood pressure, 134 +/- 15/86 +/- 12 mm Hg), we determined LV mass (2-dimensionally guided M-mode echocardiography), urinary aldosterone concentration, and the response of aldosterone to angiotensin II infusion (3.0 ng/kg/min). Seventy-six volunteers took part in a follow-up visit after 2 years when urinary aldosterone concentration and LV mass were determined again. At follow-up, LV mass increased in 42 subjects (by 33 +/- 26 g), whereas in 34 subjects LV mass decreased (by 27 +/- 22 g). Between the 2 groups, only the change in urinary aldosterone concentration over time was significantly different (group with increased LV mass had an increase in urinary aldosterone concentration by 2.5 +/- 5.4 microg/day; group with decreased LV mass had a decrease in urinary aldosterone concentration by 0.7 +/- 4.6; p <0.01 between groups). In accordance, we found significant correlations between changes in LV mass and changes in urinary aldosterone concentration (r = 0.29, p <0.05) and between changes in LV mass and the response of aldosterone to angiotensin II at baseline (r = 0.25, p <0.05). Both changes in aldosterone concentration over time and the response of aldosterone to angiotensin II were related to changes in LV mass over time. These data underscore the importance of aldosterone for the development of LV hypertrophy. This process is already evident in young subjects with apparently small changes in LV mass over a mean follow-up period of 2 years.
Delles
Christian
C
Department of Medicine IV/4, University of Erlangen-Nürnberg, Nürnberg, Germany.
Schmidt
Bernhard M W
BM
Müller
Hans J
HJ
Oehmer
Sebastian
S
Klingbeil
Arnfried U
AU
Schmieder
Roland E
RE
D000328:Adult; D000450:Aldosterone / Q000502:physiology* / Q000652:urine; D000804:Angiotensin II / Q000494:pharmacology; D004347:Drug Interactions; D004452:Echocardiography; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000378:metabolism*; D008297:Male; D017673:Sodium Chloride, Dietary / Q000009:adverse effects
D017673:Sodium Chloride, Dietary; D000804:Angiotensin II; D000450:Aldosterone